National Health (Continued Dispensing) Amendment Determination 2022 (No. 1) (Cth)
PB 88 of 2022
National Health (Continued Dispensing) Amendment Determination 2022
(No. 1)
National Health Act 1953
I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 89A(3) of the National Health Act 1953.
Dated 29 September 2022
NIKOLAI TSYGANOV
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Contents
1 Name…………………………………………………………………………….………………1
2.......... Commencement............................................................................................................................ 1
3.......... Authority...................................................................................................................................... 1
4 ......... Schedule....................................................................................................................................... 1
Schedule 1—Amendments 2
National Health (Continued Dispensing) Determination 2022 (PB 59 of 2022) 2
1 Name
(1)This instrument is the National Health (Continued Dispensing) Amendment Determination 2022 (No. 1).
(2)This instrument may also be cited as PB 88 of 2022.
2 Commencement
(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 October 2022 | 1 October 2022 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
Authority
This instrument is made under subsection 89A(3) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Continued Dispensing) Determination 2022 (PB 59 of 2022)
Schedule 1, Section 1
omit table and substitute:
| Item | Listed drug |
| 1 | Abacavir |
| 2 | Abacavir with lamivudine |
| 3 | Abacavir with lamivudine and zidovudine |
| 4 | Acarbose |
| 5 | Adefovir |
| 6 | Alogliptin |
| 7 | Alogliptin with metformin |
| 8 | Amlodipine |
| 9 | Amlodipine with atorvastatin |
| 10 | Amlodipine with valsartan |
| 11 | Amlodipine with valsartan and hydrochlorothiazide |
| 12 | Atazanavir |
| 13 | Atazanavir with cobicistat |
| 14 | Atenolol |
| 15 | Atorvastatin |
| 16 | Beclometasone |
| 17 | Beclometasone with formoterol |
| 18 | Bictegravir with emtricitabine with tenofovir alafenamide |
| 19 | Bisoprolol |
| 20 | Budesonide |
| 21 | Budesonide with formoterol |
| 22 | Candesartan |
| 23 | Candesartan with hydrochlorothiazide |
| 24 | Captopril |
| 25 | Carvedilol |
| 26 | Chlortalidone |
| 27 | Ciclesonide |
| 28 | Cromoglycic acid |
| 29 | Dapagliflozin |
| 30 | Dapagliflozin with metformin |
| 31 | Darunavir |
| 32 | Darunavir with cobicistat |
| 33 | Darunavir with cobicistat, emtricitabine and tenofovir alafenamide |
| 34 | Diltiazem |
| 35 | Dolutegravir |
| 36 | Dolutegravir with abacavir and lamivudine |
| 37 | Dolutegravir with lamivudine |
| 38 | Dolutegravir with rilpivirine |
| 39 | Dulaglutide |
| 40 | Efavirenz |
| 41 | Empagliflozin |
| 42 | Empagliflozin with linagliptin |
| 43 | Empagliflozin with metformin |
| 44 | Emtricitabine with rilpivirine with tenofovir alafenamide |
| 45 | Emtricitabine with tenofovir alafenamide |
| 46 | Enalapril |
| 47 | Enalapril with hydrochlorothiazide |
| 48 | Enfuvirtide |
| 49 | Entecavir |
| 50 | Eplerenone |
| 51 | Eprosartan |
| 52 | Eprosartan with hydrochlorothiazide |
| 53 | Ertugliflozin |
| 54 | Ertugliflozin with metformin |
| 55 | Ertugliflozin with sitagliptin |
| 56 | Etravirine |
| 57 | Exenatide |
| 58 | Ezetimibe and rosuvastatin |
| 59 | Ezetimibe with atorvastatin |
| 60 | Ezetimibe with simvastatin |
| 61 | Felodipine |
| 62 | Fluticasone furoate |
| 63 | Fluticasone furoate with vilanterol |
| 64 | Fluticasone propionate |
| 65 | Fluticasone propionate with formoterol |
| 66 | Fluticasone propionate with salmeterol |
| 67 | Fluvastatin |
| 68 | Formoterol |
| 69 | Fosamprenavir |
| 70 | Fosinopril |
| 71 | Fosinopril with hydrochlorothiazide |
| 72 | Furosemide |
| 73 | Glibenclamide |
| 74 | Gliclazide |
| 75 | Glimepiride |
| 76 | Glipizide |
| 77 | Hydrochlorothiazide |
| 78 | Hydrochlorothiazide with amiloride |
| 79 | Indacaterol |
| 80 | Indacaterol with mometasone |
| 81 | Indapamide |
| 82 | Insulin aspart |
| 83 | Insulin aspart with insulin aspart protamine suspension |
| 84 | Insulin degludec with insulin aspart |
| 85 | Insulin detemir |
| 86 | Insulin glargine |
| 87 | Insulin glulisine |
| 88 | Insulin isophane |
| 89 | Insulin lispro |
| 90 | Insulin lispro with insulin lispro protamine suspension |
| 91 | Insulin neutral |
| 92 | Insulin neutral with insulin isophane |
| 93 | Irbesartan |
| 94 | Irbesartan with hydrochlorothiazide |
| 95 | Labetalol |
| 96 | Lamivudine |
| 97 | Lamivudine with zidovudine |
| 98 | Lercanidipine |
| 99 | Lercanidipine with enalapril |
| 100 | Levonorgestrel |
| 101 | Levonorgestrel with ethinylestradiol |
| 102 | Linagliptin |
| 103 | Linagliptin with metformin |
| 104 | Lisinopril |
| 105 | Lopinavir with ritonavir |
| 106 | Losartan |
| 107 | Maraviroc |
| 108 | Metformin |
| 109 | Metoprolol |
| 110 | Metoprolol succinate |
| 111 | Nebivolol |
| 112 | Nevirapine |
| 113 | Nifedipine |
| 114 | Norethisterone |
| 115 | Norethisterone with ethinylestradiol |
| 116 | Norethisterone with mestranol |
| 117 | Olmesartan |
| 118 | Olmesartan with amlodipine |
| 119 | Olmesartan with amlodipine and hydrochlorothiazide |
| 120 | Olmesartan with hydrochlorothiazide |
| 121 | Oxprenolol |
| 122 | Perindopril |
| 123 | Perindopril with amlodipine |
| 124 | Perindopril with indapamide |
| 125 | Pindolol |
| 126 | Pioglitazone |
| 127 | Pravastatin |
| 128 | Propranolol |
| 129 | Quinapril |
| 130 | Quinapril with hydrochlorothiazide |
| 131 | Raltegravir |
| 132 | Ramipril |
| 133 | Ramipril with felodipine |
| 134 | Rilpivirine |
| 135 | Ritonavir |
| 136 | Rosuvastatin |
| 137 | Sacubitril with valsartan |
| 138 | Salbutamol |
| 139 | Salmeterol |
| 140 | Saquinavir |
| 141 | Saxagliptin |
| 142 | Saxagliptin with dapagliflozin |
| 143 | Saxagliptin with metformin |
| 144 | Semaglutide |
| 145 | Simvastatin |
| 146 | Sitagliptin |
| 147 | Sitagliptin with metformin |
| 148 | Spironolactone |
| 149 | Telmisartan |
| 150 | Telmisartan with amlodipine |
| 151 | Telmisartan with hydrochlorothiazide |
| 152 | Tenofovir |
| 153 | Tenofovir alafenamide with emtricitabine, elvitegravir and cobicistat |
| 154 | Tenofovir with emtricitabine |
| 155 | Tenofovir with emtricitabine and efavirenz |
| 156 | Terbutaline |
| 157 | Tipranavir |
| 158 | Trandolapril |
| 159 | Trandolapril with verapamil |
| 160 | Valsartan |
| 161 | Valsartan with hydrochlorothiazide |
| 162 | Verapamil |
| 163 | Vildagliptin |
| 164 | Vildagliptin with metformin |
| 165 | Zidovudine |
0
0
0